RESEARCH GOAL
Redox & Skin
Endogenous redox and remodeling biology interpreted by route, formulation, and measured outcome.
ASK BETTER QUESTIONS
What changes a redox & skin evidence decision?
- Which route and formulation were studied?
- Was the outcome clinical or only a biomarker?
- Does sterile-product quality change the risk?
EVIDENCE RECORDS
Redox & Skin evidence records.
Native peptideHuman evidence 3/5
Glutathione
Glutathione evidence is inseparable from route, formulation, outcome, and product quality. Oral biomarker studies do not establish intravenous efficacy or safety.
Open evidence recordNative peptideHuman evidence 2/5
GHK-Cu
GHK-Cu is biologically active and has limited topical human research, but the evidence does not validate broad injectable, systemic, or anti-aging claims.
Open evidence recordSynthetic peptideHuman evidence 3/5
SS-31 / Elamipretide
SS-31 is no longer simply an unapproved research peptide: elamipretide now has one narrow accelerated-approval pathway, with confirmatory evidence still required.
Open evidence record